Tag: AXINON

FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform

THE WOODLANDS, Texas and REGENSBURG, Germany, July 25, 2023 /PRNewswire/ — The US Food and Drug Administration has cleared a Numares Health test, the AXINON® LDL-p Test System, as a new tool physicians can use to measure lipoproteins for patients at risk for cardiovascular disease. Currently, Numares is the only company in the US selling an FDA-cleared […]

numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics

BOSTON, United States & REGENSBURG, Germany–(BUSINESS WIRE)–Leading metabolomics based diagnostics company numares AG and analytical instrumentation and solution provider Bruker Corporation have signed an agreement to collaborate to bring new diagnostics tests utilizing NMR to the laboratory market for unmet medical needs. The tests are based on the automated measurement of metabolites using a […]